{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:13:32Z","timestamp":1772223212004,"version":"3.50.1"},"reference-count":41,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,5,10]],"date-time":"2010-05-10T00:00:00Z","timestamp":1273449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contact Dermatitis"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:p> <jats:italic>Background:<\/jats:italic> While the use of methyldibromo glutaronitrile (MDBGN) in leave\u2010on products is clearly associated with high sensitization or elicitation risk, such a clear\u2010cut relation could be questioned with regard to rinse\u2010off products.<\/jats:p><jats:p> <jats:italic>Objective:<\/jats:italic> The objective of this study was to find a maximum non\u2010eliciting concentration for rinse\u2010off products in MDBGN patch test\u2010positive patients.<\/jats:p><jats:p> <jats:italic>Patients and methods:<\/jats:italic> We performed a use\u2010related test [repeated open application test (ROAT)] in patients sensitized to MDBGN with a liquid soap containing three concentrations of MDBGN (50, 200, and 400 p.p.m. MDBGN, respectively). The soap at 50 p.p.m. was used twice daily for 4 weeks. If no reaction of the skin was observed, the product with the next higher concentration was used for another 4 weeks, etc.<\/jats:p><jats:p> <jats:italic>Results:<\/jats:italic> In total, 32\/37 evaluated cases [86.5%; lower exact one\u2010sided 95% confidence limit (CL): 73.7%] did not react to any of the preparations. The remaining reacted as follows: 1\/37 reacted to 50 p.p.m., 3\/37 to 200 p.p.m., and 1\/37 to 400 p.p.m. The cumulative non\u2010response to 50 p.p.m. was 97.3% (lower CL: 87.8%).<\/jats:p><jats:p> <jats:italic>Conclusions:<\/jats:italic> The majority of subjects sensitized to MDBGN\u2010tolerated rinse\u2010off products containing a maximum concentration of 400 p.p.m. A concentration in rinse\u2010off products in the range of 50 p.p.m. could be regarded as safe for most individuals already sensitized. These concentrations will presumably prevent induction (sensitization) also.<\/jats:p>","DOI":"10.1111\/j.1600-0536.2010.01726.x","type":"journal-article","created":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T05:59:48Z","timestamp":1273557588000},"page":"330-337","source":"Crossref","is-referenced-by-count":12,"title":["Quantitative repeated open application testing with a rinse\u2010off product in methyldibromo glutaronitrile\u2010sensitive patients: results of the IVDK"],"prefix":"10.1111","volume":"62","author":[{"given":"Annice","family":"Heratizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Killig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margitta","family":"Worm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Soost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagmar","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Szliska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Frambach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricarda","family":"Eben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Werfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Uter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Schnuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,5,10]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1998.02126.x"},{"key":"e_1_2_6_3_2","first-page":"151","article-title":"Contact allergy to Euxyl K 400.","volume":"39","author":"Fuchs T","year":"1991","journal-title":"Dermatosen"},{"key":"e_1_2_6_4_2","first-page":"399","article-title":"Zunahme der Kontaktallergien gegen Methyldibromoglutaronitril in Deutschland","volume":"19","author":"Geier J","year":"1996","journal-title":"Allergologie"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1991.tb01794.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb16949.x"},{"key":"e_1_2_6_7_2","first-page":"175","article-title":"Sensitization to Euxyl K 400, a prospective study in 1,217 patients","volume":"6","author":"Vigan M","year":"1996","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.470107.x"},{"key":"e_1_2_6_9_2","first-page":"23","article-title":"Commission directive 2003\/83\/EC of 24 September 2003","volume":"238","author":"Commission of the European Communities","year":"2003","journal-title":"Official J Eur Union"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06145.x"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00529.x"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03361953"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2008.01364.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2003.480212_5.x"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00524.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2000.042002064.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1995.tb00671.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2003.0233.x"},{"key":"e_1_2_6_19_2","unstructured":"SCCP.Scientific Committee on Consumer Products Opinion on Methydibromoglutaronitrile (sensitisation only) SCCP\/0863\/05 2005. Available at:http:\/\/ec.europa.eu\/health\/ph_risk\/committees\/04_sccp\/docs\/sccp_o_00f.pdf(last accessed 25 January 2010)."},{"key":"e_1_2_6_20_2","first-page":"27","article-title":"Commission directive 2007\/17\/EC of 22 March 2007","volume":"82","author":"Commission of the European Communities","year":"2007","journal-title":"Official J Eur Union"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2009.01601.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/oem.51.6.371"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2003.00126.x"},{"key":"e_1_2_6_24_2","first-page":"36","article-title":"Epidemiology of contact dermatitis: the Information Network of the Departments of Dermatology (IVDK) in Germany\u2014a surveillance system on contact allergies","volume":"8","author":"Uter W","year":"1998","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1986.tb01229.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.1998.tb05850.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05727.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050170048"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-31301-X_22"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00406.x"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02162161"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.5414\/ALP25415"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2003.00076.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00478.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2340\/00015555-0009","article-title":"Increased retest reactivity by both path and use test with methyldibromo glutaronitrile in sensitized individuals.","volume":"86","author":"Jensen C D","year":"2006","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-31301-X_19"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2005.00505.x"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00259.x"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2004.06.017"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2001.450603.x"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/01634989-199409000-00004"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01590.x"}],"container-title":["Contact Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0536.2010.01726.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0536.2010.01726.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:10:03Z","timestamp":1698711003000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0536.2010.01726.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,10]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1600-0536.2010.01726.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0536.2010.01726.x","archive":["Portico"],"relation":{},"ISSN":["0105-1873","1600-0536"],"issn-type":[{"value":"0105-1873","type":"print"},{"value":"1600-0536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,10]]}}}